Prosight Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-61,400
Closed -$8.21M 47
2018
Q4
$8.21M Buy
61,400
+30,000
+96% +$4.92M 4.24% 9
2018
Q3
$5.98M Sell
31,400
-40,300
-56% -$7.4M 3.34% 12
2018
Q2
$12M Sell
71,700
-23,100
-24% -$3.71M 8.76% 3
2018
Q1
$16M Sell
94,800
-3,200
-3% -$537K 10.01% 2
2017
Q4
$16M Buy
+98,000
New +$17.6M 11.79% 1

Other funds holding AGN

Prosight Management's AGN Position: Q1 2019 in Review

Prosight Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 61,400 shares — an estimated $8.21M sold.

Prosight Management first reported a position in AGN in Q4 2017 and held it in 5 quarters. The position peaked at $16M in Q4 2017. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Prosight Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Prosight Management sold 61,400 Allergan plc shares in Q1 2019, an estimated $8.21M.
  • Prosight Management first reported a position in Allergan plc in Q4 2017 and held it in 5 quarters.
  • Prosight Management's Allergan plc position peaked at $16M in Q4 2017.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Prosight Management's 13F filing for Q1 2019, filed 15 May 2019.